Brewer Sports International (BSI), a multi-faceted global sports
advisory firm, and Amarantus Bioscience Holdings, Inc.
(OTCQB:AMBS), a biotechnology company focused on the discovery and
development of novel diagnostics and therapeutics related to cell
cycle dysregulation, endoplasmic reticulum stress,
neurodegeneration and apoptosis, are pleased to announce their
continued support of One Mind at the 3rd Alzheimer's focused #C4CT
(Coalition for Concussion Treatment) Concussion Awareness Summit,
powered by MDM Worldwide on Thursday, July 31, 2014 at the United
Nations in New York City, NY.
ONE MIND is an independent, 501 (c)(3) non-profit organization
devoted to bringing together the public and private sectors to
collaborate on large-scale, shared data research for all diseases
of the brain; research that will accelerate the development and
implementation of improved diagnostics, treatments, and cures for
patients.
"Forging partnerships and
collaborations are critical to making much needed progress in
finding better diagnostics and treatments for concussions, CTE's
and TBI's in sports and beyond."
- Pete Chiarelli, CEO of One Mind,
U.S. Army General (Retired)
The #C4CT Concussion Awareness Summit is being convened on July
31, 2014 to explore the potential link between TBI and Alzheimer's
disease. A diverse working group of clinicians, medical
researchers, policy makers, international diplomats, athletes,
celebrities, and philanthropic organizations will be assembled to
raise awareness, advance clinical research, and develop public
policy in order to address this major unmet medical need and public
health issue.
The Summit will feature multiple panelists and presenters
including an opening keynote by The Honorable Chaka Fattah
(D-PA), Member of Congress; Chris
Nowinski, Co- Founder & Executive Director of Sports
Legacy Institute, Co-Director for the Center for the Study of
Traumatic Encephalopathy at Boston University School of Medicine
and Former WWE Wrestler; Robert Stern, Ph.D.,
Professor of Neurology, Neurosurgery, and Anatomy and Neurobiology
and Clinical Core Director of BU Alzheimer's Disease Center, Boston
University School of Medicine; and Robert Cantu, M.A.,
M.D., F.A.C.S., F.A.A.N.S., F.I.C.S., F.A.C.S.M.,
Boston University School of Medicine and Sport Legacy Institute
(SLI). There will also be a special panel of current and former
professional athletes who will share personal stories about their
experiences with concussions.
To register or for additional information, please visit
www.c4ctsummit.com. For further event questions, please contact
Lindsay Lommel at lindsay.lommel@thebrewergroup.com. For
sponsorship information please visit:
http://www.c4ctsummit.com/sponsorship-opportunities/.
About Amarantus BioScience Holdings, Inc.
Amarantus BioScience Holdings (AMBS) is a biotechnology company
developing treatments and diagnostics for diseases associated with
neurodegeneration and protein misfolding-related apoptosis. AMBS
has licensed Eltoprazine ("Eltoprazine"), a phase 2b ready
indication for Parkinson's Levodopa induced dyskinesia and Adult
ADHD. AMBS has an exclusive worldwide license to the Lymphocyte
Proliferation test ("LymPro Test(R)") for Alzheimer's disease and
owns the intellectual property rights to a therapeutic protein
known as Mesencephalic-Astrocyte-derived Neurotrophic Factor
("MANF") and is developing MANF-based products as treatments for
brain disorders. AMBS also owns intellectual property for the
diagnosis of Parkinson's disease ("NuroPro") and the discovery of
neurotrophic factors ("PhenoGuard"). Amarantus operations are
located at Janssen Labs @QB3 in San Francisco, CA. For further
information please visit www.Amarantus.com, or connect with the
Company on Facebook, LinkedIn, Twitter and Google+.
About Brewer Sports International
Brewer Sports International (BSI) is a multi-faceted sports
advisory firm within The Brewer Group Companies with a focus on the
business of sports, wellness and media for professional athletes,
sports agencies, public and private corporations and various
partners including international organizations, governments and
NGOs. Jack Brewer, five-year National Football League (NFL) veteran
and former three-team captain, launched BSI in Minneapolis and
expanded to New York, Dallas, Miami, Beijing and Malawi. BSI offers
a unique financial services platform to professional athletes and
sports agencies, as well as high-net-worth individuals and
businesses related to professional sports. BSI takes pride in
enabling its clients to capitalize on the endless opportunities
presented through sport. For more information, please visit
www.brewersports.com or follow them on Facebook, Twitter and
LinkedIn.
About One Mind
One Mind is an independent, 501(c)(3) non-profit organization
dedicated to benefiting all affected by brain illness and injury
through fostering fundamental changes that will radically
accelerate the development and implementation of improved
diagnostics, treatments, and cures; while eliminating the
stigma. One Mind believes in open science principles and
creates global public-private partnerships between governmental,
corporate, scientific, and philanthropic communities. Visit us at
www.onemind.org or follow us via Twitter or Facebook.
About MDM Worldwide
MDM Worldwide Solutions, Inc. is a digital communications agency
that develops and manages online engagement strategies to connect
companies with their stakeholders. MDM specializes in working with
clients in the technology, healthcare and life sciences spaces.
MDM's vast industry knowledge, proprietary methodology, proven
track record and experienced leadership team enables them to create
and customize targeted digital marketing campaigns to fulfill all
of their clients' objectives. For more information, please visit
mdmworldwide.com or find them on Facebook, Twitter, Google+ and
LinkedIn.
CONTACT: Brewer Sports International:
Kristi Hofacker, Interactive Marketing and Media Manager
651.247.4460
kristi.hofacker@thebrewergroup.com
Amarantus Bioscience Holdings, Inc.:
Aimee Boutcher, Investor Relations
408.737.2734 x 101
ir@amarantus.com
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Apr 2023 to Apr 2024